AMERIPRISE FINANCIAL INC - ORAMED PHARMACEUTICALS INC ownership

ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 77 filers reported holding ORAMED PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.20 and the average weighting 0.0%.

Quarter-by-quarter ownership
AMERIPRISE FINANCIAL INC ownership history of ORAMED PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$256,000
+187.6%
39,525
+102.4%
0.00%
Q2 2022$89,000
-68.3%
19,525
-39.9%
0.00%
Q1 2022$281,000
-32.6%
32,500
+11.2%
0.00%
Q4 2021$417,000
-43.5%
29,235
-12.9%
0.00%
Q3 2021$738,000
+504.9%
33,560
+180.3%
0.00%
Q1 2021$122,000
+6000.0%
11,972
+3890.7%
0.00%
Q3 2014$2,0003000.00%
Other shareholders
ORAMED PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
MORGAN JESS S & CO INC 315,301$1,444,0001.50%
Private Portfolio Partners LLC 54,010$247,3660.07%
Knoll Capital Management, LLC 20,000$92,0000.05%
Urban Wealth Management, LLC 2,858$13,0000.04%
OCCUDO QUANTITATIVE STRATEGIES LP 100,216$459,0000.04%
XTX Topco Ltd 18,174$83,0000.03%
Rossmore Private Capital 40,661$186,0000.03%
Ergoteles LLC 224,700$1,029,0000.03%
ETF MANAGERS GROUP, LLC 87,365$393,0000.01%
Belvedere Trading LLC 40,690$343,0000.01%
View complete list of ORAMED PHARMACEUTICALS INC shareholders